vs

Side-by-side financial comparison of Braze, Inc. (BRZE) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $190.8M, roughly 1.4× Braze, Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -18.9%, a 19.6% gap on every dollar of revenue. On growth, Braze, Inc. posted the faster year-over-year revenue change (25.5% vs -16.5%). Braze, Inc. produced more free cash flow last quarter ($19.0M vs $3.4M).

Braze, Inc. is an American cloud-based software company based in New York City. It is a customer engagement platform used by businesses for multichannel marketing.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

BRZE vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.4× larger
HCM
$270.8M
$190.8M
BRZE
Growing faster (revenue YoY)
BRZE
BRZE
+42.1% gap
BRZE
25.5%
-16.5%
HCM
Higher net margin
HCM
HCM
19.6% more per $
HCM
0.7%
-18.9%
BRZE
More free cash flow
BRZE
BRZE
$15.7M more FCF
BRZE
$19.0M
$3.4M
HCM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BRZE
BRZE
HCM
HCM
Revenue
$190.8M
$270.8M
Net Profit
$-36.0M
$2.0M
Gross Margin
67.2%
37.7%
Operating Margin
-19.7%
-13.2%
Net Margin
-18.9%
0.7%
Revenue YoY
25.5%
-16.5%
Net Profit YoY
-29.0%
-83.6%
EPS (diluted)
$-0.33
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRZE
BRZE
HCM
HCM
Q4 25
$190.8M
$270.8M
Q3 25
$180.1M
Q2 25
$162.1M
$277.7M
Q1 25
$160.4M
$324.5M
Q4 24
$152.1M
Q3 24
$145.5M
Q2 24
$135.5M
$305.7M
Q1 24
$131.0M
Net Profit
BRZE
BRZE
HCM
HCM
Q4 25
$-36.0M
$2.0M
Q3 25
$-27.9M
Q2 25
$-35.8M
$455.0M
Q1 25
$-17.2M
$11.9M
Q4 24
$-27.9M
Q3 24
$-23.0M
Q2 24
$-35.6M
$25.8M
Q1 24
$-28.3M
Gross Margin
BRZE
BRZE
HCM
HCM
Q4 25
67.2%
37.7%
Q3 25
67.7%
Q2 25
68.6%
0.1%
Q1 25
69.3%
48.0%
Q4 24
69.8%
Q3 24
70.2%
Q2 24
67.1%
41.1%
Q1 24
67.2%
Operating Margin
BRZE
BRZE
HCM
HCM
Q4 25
-19.7%
-13.2%
Q3 25
-21.5%
Q2 25
-24.8%
-1.3%
Q1 25
-13.4%
-5.0%
Q4 24
-21.4%
Q3 24
-19.2%
Q2 24
-29.6%
-9.0%
Q1 24
-24.7%
Net Margin
BRZE
BRZE
HCM
HCM
Q4 25
-18.9%
0.7%
Q3 25
-15.5%
Q2 25
-22.1%
163.8%
Q1 25
-10.7%
3.7%
Q4 24
-18.4%
Q3 24
-15.8%
Q2 24
-26.3%
8.4%
Q1 24
-21.6%
EPS (diluted)
BRZE
BRZE
HCM
HCM
Q4 25
$-0.33
$0.00
Q3 25
$-0.26
Q2 25
$-0.34
$0.52
Q1 25
$-0.17
$0.01
Q4 24
$-0.27
Q3 24
$-0.23
Q2 24
$-0.35
$0.03
Q1 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRZE
BRZE
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$97.8M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$602.0M
$1.2B
Total Assets
$1.0B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRZE
BRZE
HCM
HCM
Q4 25
$97.8M
$1.4B
Q3 25
$81.0M
Q2 25
$231.5M
$1.4B
Q1 25
$83.1M
$836.1M
Q4 24
$61.3M
Q3 24
$79.1M
Q2 24
$74.8M
$802.5M
Q1 24
$68.2M
Total Debt
BRZE
BRZE
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
BRZE
BRZE
HCM
HCM
Q4 25
$602.0M
$1.2B
Q3 25
$598.9M
Q2 25
$474.4M
$1.2B
Q1 25
$474.9M
$759.9M
Q4 24
$458.1M
Q3 24
$453.7M
Q2 24
$436.1M
$740.1M
Q1 24
$444.2M
Total Assets
BRZE
BRZE
HCM
HCM
Q4 25
$1.0B
$1.8B
Q3 25
$1.0B
Q2 25
$889.1M
$1.8B
Q1 25
$871.0M
$1.3B
Q4 24
$842.0M
Q3 24
$825.6M
Q2 24
$816.1M
$1.3B
Q1 24
$810.9M
Debt / Equity
BRZE
BRZE
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRZE
BRZE
HCM
HCM
Operating Cash FlowLast quarter
$21.0M
$8.2M
Free Cash FlowOCF − Capex
$19.0M
$3.4M
FCF MarginFCF / Revenue
10.0%
1.2%
Capex IntensityCapex / Revenue
1.0%
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$63.3M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRZE
BRZE
HCM
HCM
Q4 25
$21.0M
$8.2M
Q3 25
$7.0M
Q2 25
$24.1M
$-72.9M
Q1 25
$17.1M
$40.3M
Q4 24
$-11.4M
Q3 24
$11.6M
Q2 24
$19.4M
$-39.8M
Q1 24
$3.8M
Free Cash Flow
BRZE
BRZE
HCM
HCM
Q4 25
$19.0M
$3.4M
Q3 25
$4.3M
Q2 25
$23.9M
$-82.2M
Q1 25
$16.0M
$32.5M
Q4 24
$-13.3M
Q3 24
$8.3M
Q2 24
$12.5M
$-49.9M
Q1 24
$-2.5M
FCF Margin
BRZE
BRZE
HCM
HCM
Q4 25
10.0%
1.2%
Q3 25
2.4%
Q2 25
14.8%
-29.6%
Q1 25
10.0%
10.0%
Q4 24
-8.8%
Q3 24
5.7%
Q2 24
9.2%
-16.3%
Q1 24
-1.9%
Capex Intensity
BRZE
BRZE
HCM
HCM
Q4 25
1.0%
1.8%
Q3 25
1.4%
Q2 25
0.1%
3.3%
Q1 25
0.7%
2.4%
Q4 24
1.3%
Q3 24
2.3%
Q2 24
5.1%
3.3%
Q1 24
4.8%
Cash Conversion
BRZE
BRZE
HCM
HCM
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRZE
BRZE

Subscription Revenue$181.7M95%
Professional Services Revenue$9.2M5%

HCM
HCM

Segment breakdown not available.

Related Comparisons